Skip to main content

SkinHealth Systems Inc. (SKIN) Stock Forecast

Data as of Oct 31, 2026

Healthcare · Current price $10.07 (-0.79%)

Consensus Target
$1.50
Upside
-15.6%
Analysts
2
Rating
Buy(2.50)

Price Target Range

Low $1.00Consensus $1.50High $2.00
▲ Current $10.07

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Sep 19, 2025George KellyRoth Capital$3.50-65.2%
May 5, 2025Susan AndersonCanaccord Genuity$1.25-87.6%
Aug 9, 2024Korinne WolfmeyerPiper Sandler$1.00-90.1%
May 10, 2024Korinne WolfmeyerPiper Sandler$2.50-75.2%
Mar 13, 2024Korinne WolfmeyerPiper Sandler$3.00-70.2%
Mar 13, 2024Jonathan BlockStifel Nicolaus$4.00-60.3%

SKIN vs Sector & Market

MetricSKINHealthcare AvgLarge Cap Avg
Analyst Rating2.502.252.41
Analyst Count2819
Target Upside-15.6%+153002.0%+21.5%
P/E Ratio-11.193.4838.49

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$82M$83M$84M5
2027-03-31$68M$69M$70M3
2027-06-30$78M$79M$80M3
2027-09-30$72M$73M$75M3
2027-12-31$85M$86M$88M3
2028-12-31$322M$322M$322M3

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-0.01$-0.01$-0.011
2027-03-31$-0.06$-0.06$-0.051
2027-06-30$-0.04$-0.04$-0.031
2027-09-30$-0.06$-0.06$-0.061
2027-12-31$-0.04$-0.04$-0.031
2028-12-31$-0.16$-0.14$-0.123

Frequently Asked Questions

What is the analyst consensus for SKIN?

The consensus among 2 analysts covering SkinHealth Systems Inc. (SKIN) is Buy with an average price target of $1.50.

What is the highest price target for SKIN?

The highest price target for SKIN is $4.00, set by Jonathan Block at Stifel Nicolaus on 2024-03-13.

What is the lowest price target for SKIN?

The lowest price target for SKIN is $1.00, set by Korinne Wolfmeyer at Piper Sandler on 2024-08-09.

How many analysts cover SKIN?

2 analysts have issued ratings for SkinHealth Systems Inc. in the past 12 months.

Is SKIN a buy or sell right now?

Based on 2 analyst ratings, SKIN has a consensus rating of Buy (2.50/5) with a -15.6% upside to the consensus target of $1.50.

What are the earnings estimates for SKIN?

Analysts estimate SKIN will report EPS of $-0.01 for the period ending 2026-12-31, with revenue estimated at $83M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.